Abnormalities in serum biomarkers correlate with lower cardiac index in the Fontan population

Bradley S Marino1, David J Goldberg2, Adam L Dorfman3

  • 11Department of Pediatrics,Division of Cardiology,Division of Critical Care Medicine,Heart Institute,Cincinnati Children's Hospital Medical Center,Cincinnati,Ohio,United States of America.

Insights

Serum biomarkers like total alkaline phosphatase, mean corpuscular volume, and creatinine clearance can help identify Fontan survivors with low cardiac index. These markers may aid in monitoring heart function over time.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Pediatric Cardiac Surgery

Background:

  • Fontan survivors often experience declining cardiac index over time.
  • Serum biomarkers offer a minimally invasive method for serial monitoring of cardiac function.
  • Identifying reliable biomarkers is crucial for managing Fontan-associated complications.

Purpose of the Study:

  • To identify specific serum biomarkers that correlate with a depressed cardiac index in Fontan patients.
  • To assess the potential of these biomarkers for monitoring hemodynamic status.

Main Methods:

  • A multi-center case series involving Fontan patients aged 6 years and older.
  • Correlations between cardiac magnetic resonance-derived cardiac index and various biochemical/hematopoietic biomarkers were analyzed.
  • Spearman's Rank correlation and receiver operating characteristic (ROC) curve analysis were employed.

Main Results:

  • Significant inverse correlations were observed between cardiac index and total alkaline phosphatase (p=0.04) and mean corpuscular volume (p<0.01).
  • A significant positive correlation was found between cardiac index and estimated creatinine clearance (p=0.02).
  • A three-biomarker panel demonstrated an area under the ROC curve of 0.75, indicating good discriminatory power.

Conclusions:

  • Elevated total alkaline phosphatase and mean corpuscular volume, along with reduced estimated creatinine clearance, are associated with lower cardiac index in Fontan survivors.
  • These biomarkers show promise for monitoring hemodynamics and organ-specific effects in Fontan patients.
  • Further prospective studies are warranted to validate the use of these biomarkers in clinical practice.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
668
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
4.0K